Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.
1. STOCK NEWS:
- Regeneron (REGN) said that it is evaluating its REGEN-COV antibody treatment against the omicron variant [more]
- Moderna (MRNA) CEO Stephane Bancel expects current COVID-19 vaccines to struggle with the omicron variant, according to FT [more]
- The U.K.'s Competition and Markets Authority is requiring Facebook (FB), soon to be known as Meta (MVRS), to sell Giphy [more]
- ViacomCBS (VIAC) agreed to sell CBS Studio Center for $1.85B [more]
- Shopify (SHOP) said merchants' Black Friday/Cyber Monday sales rose 23% year-over-year to $6.3B [more]
2. WALL STREET CALLS:
- Square (SQ) upgraded to Neutral from Underperform at BofA [more]
- HSBC starts Beyond Meat (BYND) with a Reduce rating on "increasingly competitive" market [more]
- Rocket Lab (RKLB) initiated with a Buy at BofA [more]
- Goldman Sachs downgrades Dollar Tree (DLTR) to Neutral [more]
- Vir Biotechnology (VIR) price target raised to $200 from $135 at H.C. Wainwright [more]
3. AROUND THE WEB:
- Lululemon (LULU) filed a patent lawsuit against Peloton (PTON), CNBC reports [more]
- Dealreporter questions if Rite Aid (RAD) may become an activist target again [more]
- Merck (MRK) told Reuters it believes its COVID-19 antiviral drug will have similar activity against new variants [more]
- NetEase (NTES) shares slip on game suspension speculation, WSJ reports [more]
- Activist Bluebell is urging Glencore (GLNCY) to spin off coal assets, FT says [more]
4. MOVERS:
- MEI Pharma (MEIP) surges after announcing results from the pivotal Phase 2 TIDAL study evaluating zandelisib [more]
- ImmunityBio (IBRX) rises after entering a deal with EnGeneIC for COVID-19, cancer treatments [more]
- RedHill Biopharma (RDHL) higher after reporting quarterly results [more]
- Olema Oncology (OLMA) falls after releasing the first clinical data on OP-1250 [more]
- Intuit (INTU) lower after a 1.55M share secondary offering priced at $668.95 per share [more]
5. EARNINGS/GUIDANCE:
- Citi Trends (CTRN) provided a "beat and raise" report for Q3 [more]
- Chico's (CHS) reported upbeat Q3 earnings [more]
- JinkoSolar (JKS) reported downbeat Q3 results [more]
- Baozun (BZUN) reported better than expected Q3 earnings [more]
- Barnes & Noble Education (BNED) reported lower than expected Q3 revenue [more]
INDEXES:
Near midday, the Dow was down 611.25, or 1.74%, to 34,524.69, the Nasdaq was down 292.11, or 1.85%, to 15,490.72, and the S&P 500 was down 78.11, or 1.68%, to 4,577.16.